Part 4/8:
By 2006, the creation of the Edison machine was underway. However, no iterations of the product could perform the multitude of tests claimed by Holmes. Instead of addressing these challenges, she opted for unethical practices, including running tests on cancer patients, counting on deceit to obscure the flawed technology.
Holmes’s manipulative leadership style became evident as she fired critical voices within the company, maintaining a facade of success while preventing dissent. Faced with mounting pressure, she took drastic measures—eschewing the hire of a CFO for a decade and deceiving partners and investors alike regarding the technological capabilities of Theranos.